Wedbush Maintains Outperform on Imax, Raises Price Target to $26
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Alicia Reese has maintained an Outperform rating on Imax and raised the price target from $24 to $26.
September 03, 2024 | 4:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush analyst Alicia Reese has maintained an Outperform rating on Imax and increased the price target from $24 to $26, indicating a positive outlook.
The increase in price target from $24 to $26 by Wedbush, along with the maintained Outperform rating, suggests a positive sentiment towards Imax's future performance. This is likely to have a positive short-term impact on the stock price as investors may view this as a sign of confidence in the company's prospects.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100